AF
TGTX icon

Allworth Financial’s TG Therapeutics TGTX Stock Holding History

Allworth Financial’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$128K Buy
2,321
+1,159
+100% +$47.4K ﹤0.01% 1795
2026
Q1 		$38.6K Buy
1,162
+564
+94% +$16.8K ﹤0.01% 2517
2025
Q4 		$17.8K Buy
598
+31
+5% +$1.01K ﹤0.01% 2893
2025
Q3 		$20.5K Sell
567
-65
-10% -$2.14K ﹤0.01% 2695
2025
Q2 		$22.7K Buy
632
+23
+4% +$856 ﹤0.01% 2439
2025
Q1 		$24.5K Sell
609
-149
-20% -$5.01K ﹤0.01% 1953
2024
Q4 		$22.1K Buy
758
+21
+3% +$603 ﹤0.01% 2031
2024
Q3 		$17.2K Buy
737
+12
+2% +$262 ﹤0.01% 2006
2024
Q2 		$15.2K Hold
725
– – ﹤0.01% 2040
2024
Q1 		$11K Sell
725
-225
-24% -$3.58K ﹤0.01% 2067
2023
Q4 		$16.2K Sell
950
-13
-1% -$151 ﹤0.01% 1751
2023
Q3 		$8.05K Buy
963
+13
+1% +$181 ﹤0.01% 1916
2023
Q2 		$23.6K Hold
950
– – ﹤0.01% 1441
2023
Q1 		$14.3K Buy
950
+850
+850% +$12.9K ﹤0.01% 1644
2022
Q4 		$1.18K Hold
100
– – ﹤0.01% 2418
2022
Q3 		$1K Buy
+100
New +$656 ﹤0.01% 2516
2019
Q1 		– Sell
-62
Closed – – 1033
2018
Q4 		$0 Hold
62
– – ﹤0.01% 940
2018
Q3 		$0 Hold
62
– – ﹤0.01% 990
2018
Q2 		$1K Hold
62
– – ﹤0.01% 904
2018
Q1 		$1K Hold
62
– – ﹤0.01% 778
2017
Q4 		$1K Hold
62
– – ﹤0.01% 704
2017
Q3 		$1K Hold
62
– – ﹤0.01% 712
2017
Q2 		$1K Hold
62
– – ﹤0.01% 710
2017
Q1 		$1K Hold
62
– – ﹤0.01% 718
2016
Q4 		$0 Hold
62
– – ﹤0.01% 739
2016
Q3 		$0 Hold
62
– – ﹤0.01% 740
2016
Q2 		$0 Buy
+62
New +$504 ﹤0.01% 676

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

Allworth Financial's TGTX Position: Q2 2026 in Review

Allworth Financial increased its TG Therapeutics (TGTX) stake by 100% in Q2 2026, buying an estimated $47.4K and bringing the position to 2,321 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #1795.

Allworth Financial first reported a position in TGTX in Q2 2016 and has held it in 27 quarters since. 431 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Allworth Financial held 2,321 shares of TG Therapeutics worth $128K as of Q2 2026.
  • Allworth Financial bought 1,159 TG Therapeutics shares in Q2 2026, an estimated $47.4K.
  • TG Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #1795 holding.
  • Allworth Financial first reported a position in TG Therapeutics in Q2 2016 and has held it in 27 quarters since.
  • 431 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.